Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-17-006847
Filing Date
2017-11-09
Accepted
2017-11-09 16:57:17
Documents
5
Period of Report
2017-11-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_110917.htm 6-K 9480
2 EXHIBIT 1.1 exh_11.htm EX-1.1 311769
3 EXHIBIT 5.1 exh_51.htm EX-5.1 7962
4 EXHIBIT 5.2 exh_52.htm EX-5.2 8069
5 GRAPHIC gkh.jpg GRAPHIC 7935
  Complete submission text file 0001171843-17-006847.txt   349278
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 171191665
SIC: 2834 Pharmaceutical Preparations